MJFF awards $6m to Lario Therapeutics for Parkinson’s research
The neurological disease is estimated to affect more than ten million people globally
Read More
Tag: Michael J. Fox Foundation
Mission awarded $5.2m to advance potential Parkinson’s treatment
The progressive neurodegenerative condition affects around 153,000 people in the UK
Read More
Herantis Pharma granted €3.6m to assess treatment for Parkinson’s disease
In the UK, the progressive neurodegenerative condition affects around 153,000 people
Read More
LucyTx announces additional $12.5m research funding for neurological diseases
Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
